Physician profile
Niloufar Ehsani Ahmad
NPI 1447637913
$1,433.50
in general payments reported to CMS, 2019-2025
22 companies · $328 in 2025
The $328 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.00 · 2021: $73.85 · 2022: $233 · 2023: $364 · 2024: $394 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,060 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,059.77 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $297.07 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $147.74 | 2022-2025 | Veozah |
| Biogen, INC. | $124.48 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $108.27 | 2022-2023 | Orilissa, Lo Loestrin Fe, Liletta |
| Novo Nordisk INC | $98.76 | 2019-2024 | Wegovy |
| Coopersurgical, INC. | $92.65 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Millicent US INC | $89.77 | 2024-2025 | Intrarosa, Femlyv |
| Mayne Pharma Commercial LLC | $75.38 | 2022-2025 | |
| Agile Therapeutics, INC. | $61.75 | 2021-2022 | |
| Shield Therapeutics INC | $44.53 | 2023-2024 | Accrufer |
| Exeltis, USA INC. | $43.26 | 2019-2024 | Slynd |
| Myovant Sciences INC. | $35.34 | 2021-2022 | |
| Pfizer INC. | $35.18 | 2022-2025 | |
| Daiichi Sankyo INC. | $24.80 | 2022 | |
| Therapeuticsmd, INC. | $24.77 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $21.45 | 2021 | |
| Axonics, INC. | $20.66 | 2023 | Axonics |
| Hologic Sales and Service, LLC | $20.37 | 2024 | Fluent Fluid Management System, Novasure, Omni Hysteroscope |
| Pacira Pharmaceuticals Incorporated | $19.82 | 2022 | |
| Lilly USA, LLC | $19.15 | 2025 | Zepbound, Mounjaro |
| Exact Sciences Corporation | $14.48 | 2023 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $13.82 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Niloufar Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.